Opendata, web and dolomites

SUPAIR Spectroscopy

SUPAIR Spectroscopy: Single-Use Process Analytical Infrared Spectroscopy

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 SUPAIR Spectroscopy project word cloud

Explore the words cloud of the SUPAIR Spectroscopy project. It provides you a very rough idea of what is the project "SUPAIR Spectroscopy" about.

awarded    first    b2b    biopharmaceutical    quality    price    technologies    roadmap    affordable    150    market    revenue    innovation    costing    companies    mid    crystal    biopharma    medical    sensors    valley    silicon    patent    water    ftir    eliminates    performed    spectrometer    award    infrared    half    promoted    probes    commercial    analytical    spectroscopy    distributors    offers    impressive    compact    reactors    techniques    competing    optimal    size    solution    total    500    300    fourier    monitoring    time    requiring    company    exist    model    scholarship    read    consecutive    complete    efficiency    monitored    expensive    reused    irubis    cells    cell    flow    merck    automated    consumption    atr    industry    biologic    mammalian    200    flexible    energy    sales    cultivating    single    billion    sme    drugs    direct    feasibility    solutions    merits    mir    streams    attenuated    savings    transform    business    bioreactors    optical    team    sterilization    pat    pending    sub    poised    customers    usually    online    accelerator    2025    reflectance    render    carry   

Project "SUPAIR Spectroscopy" data sheet

The following table provides information about the project.

Coordinator
IRUBIS GMBH 

Organization address
address: SCHILLERSTRASSE 40 B
city: MUNCHEN
postcode: 80336
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Project website https://irubis.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-05-01   to  2019-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    IRUBIS GMBH DE (MUNCHEN) coordinator 50˙000.00

Map

 Project objective

The biopharmaceutical industry is poised to reach an impressive market size of more than €300 billion by 2025. The production of biologic drugs is usually performed by cultivating mammalian cells within bioreactors. Those reactors are increasingly being monitored online by means of Process Analytical Technologies (PAT). However state-of-the-art techniques render both sub-optimal product quality and product efficiency. A complete mid-infrared (MIR) spectroscopy system using online Attenuated Total Reflectance (ATR) probes is highly expensive costing around €200,000, €20,000 only for the probes that are not robust enough, requiring consecutive sterilization to be reused (raising water and energy consumption). IRUBIS GmbH team goal is to make online monitoring of (single-use) bioreactors affordable. IRUBIS innovation comprises a single-use patent-pending silicon ATR crystal integrated in a single-use ATR Flow Cell which is read out by a compact Fourier Transform Infrared (FTIR) Spectrometer. IRUBIS Analytical Technology offers a system that will allow for the first time real-time process control (online) in single-use bioreactors. This means a flexible, highly automated system solution that costs half the price of the competing solutions. Furthermore, it eliminates sterilization requirements allowing for important energy savings. IRUBIS has been awarded an accelerator program promoted by Merck; Company recent merits also include the Medical valley award (€500,000) and the Exist scholarship (€150,000). Our business model will be based in two revenue streams: B2B direct sales of developed IRUBIS optical sensors to biopharma companies and sales through partnerships with distributors. The feasibility study we will carry out under this SME Phase 1 project, will define the technical, market and commercial roadmap allowing to offer customers a higher value product.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SUPAIR SPECTROSCOPY" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SUPAIR SPECTROSCOPY" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Totem Spoon (2019)

Interactive Digital Signage with emotional intelligence for smart cities

Read More  

RDNA (2019)

Empowering New Venture Growth - RDNA

Read More  

MEDIVAC (2019)

Machine learning software to design personalized neoantigen vaccines tailored to specific vaccine delivery systems

Read More